We used univariate logistic regression variables (BMI, age, E/e’, and LAVI), which were structured depending on their median value in the entire T2DM HF population, the cut-off point level of adropin, and the presence versus absence of several conditions, including left ventricular (LV) hypertrophy, atrial fibrillation, and the use of SGLT2 inhibitors (Table 2). This evidence concerns the gene SLC5A2 and atrial fibrillation.